Edoardo Malfatti Selected Research

Calcium

1/2020

European muscle MRI study in limb girdle muscular dystrophy type R1/2A (LGMDR1/LGMD2A).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Edoardo Malfatti Research Topics

Disease

37	Muscular Diseases (Myopathy) 03/2024 - 01/2013
7	Nemaline Myopathies (Nemaline Myopathy) 01/2022 - 12/2013
6	Congenital Structural Myopathies (Centronuclear Myopathy) 12/2023 - 12/2014
5	Muscle Weakness 01/2023 - 05/2012
5	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 01/2022 - 01/2019
4	Central Core Myopathy (Central Core Disease) 03/2024 - 11/2017
4	Cardiomyopathies (Cardiomyopathy) 01/2024 - 09/2015
4	Glycogen Storage Disease (Glycogenosis) 09/2020 - 05/2012
3	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 10/2023 - 01/2022
3	Muscular Dystrophies (Muscular Dystrophy) 01/2023 - 12/2015
3	Limb-girdle muscular dystrophy type 2A 01/2021 - 01/2020
3	Disease Progression 01/2020 - 08/2013
3	Mitochondrial Diseases (Mitochondrial Disease) 10/2010 - 01/2007
2	Minicore Myopathy with External Ophthalmoplegia 03/2024 - 01/2020
2	Malignant Hyperthermia 03/2024 - 11/2017
2	Inborn Genetic Diseases (Disease, Hereditary) 03/2024 - 01/2020
2	Contracture 01/2024 - 12/2015
2	Arthrogryposis 01/2023 - 10/2016
2	Distal Myopathies (Distal Muscular Dystrophy) 01/2020 - 01/2017
2	Vacuolar myopathy 10/2019 - 05/2012
2	Deafness (Deaf Mutism) 04/2011 - 08/2009
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2024
1	Hypertrophy 01/2024
1	Facioscapulohumeral Muscular Dystrophy 01/2024
1	Myofibrillar Myopathy 07/2023
1	Immunoglobulin Light-chain Amyloidosis 01/2023
1	Amyloid Plaque 01/2023
1	Paraproteinemias (Monoclonal Gammopathy) 01/2023
1	Amyloidosis 01/2023
1	Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital) 01/2022
1	Lafora Disease 01/2022
1	Frontotemporal Dementia (Semantic Dementia) 01/2022
1	Osteitis Deformans (Paget's Disease of Bone) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Camptocormia 01/2021
1	Ehlers-Danlos Syndrome (Syndrome, Ehlers-Danlos) 10/2020
1	Sarcoglycanopathies 01/2020
1	Reinjuries 12/2019
1	Meige Syndrome 12/2019
1	Phosphoglycerate Kinase 1 Deficiency 01/2019
1	Atrophy 08/2018
1	Glycogen Storage Disease Type III (Cori's Disease) 01/2018
1	Neuromuscular Manifestations 01/2018

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 03/2024 - 11/2014
9	polyglucosanIBA 01/2022 - 05/2012
6	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 03/2024 - 01/2013
6	ConnectinIBA 03/2024 - 12/2015
5	GlycogenIBA 10/2023 - 12/2014
5	glycogeninIBA 01/2022 - 12/2014
4	EnzymesIBA 10/2019 - 08/2010
3	Myosins (Myosin)IBA 11/2023 - 01/2020
3	CalpainIBA 12/2020 - 12/2015
3	Mitochondrial DNA (mtDNA)IBA 08/2010 - 01/2007
2	DystrophinIBA 10/2023 - 01/2022
2	Valosin Containing ProteinIBA 01/2022 - 12/2019
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
2	Creatine Kinase (Creatine Phosphokinase)IBA 01/2021 - 01/2017
2	nebulinIBA 10/2015 - 04/2014
2	Dynamin IIIBA 04/2015 - 12/2014
2	Ser Transfer RNAIBA 04/2011 - 10/2007
2	Transfer RNA (tRNA)IBA 10/2010 - 10/2007
1	Protein Kinases (Protein Kinase)IBA 03/2024
1	Muscle Proteins (Muscle Protein)IBA 03/2024
1	Serine (L-Serine)FDA Link 03/2024
1	FilaminsIBA 01/2024
1	nusinersenIBA 01/2024
1	Antisense OligonucleotidesIBA 01/2024
1	NAD (NADH)IBA 01/2024
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2024
1	DesminIBA 07/2023
1	Immunoglobulin A (IgA)IBA 01/2023
1	daratumumabIBA 01/2023
1	Thyrotropin Receptors (Thyrotropin Receptor)IBA 01/2023
1	SteroidsIBA 01/2023
1	Amyloid (Amyloid Fibrils)IBA 01/2023
1	Laminin (Merosin)IBA 05/2022
1	Albuterol (Salbutamol)FDA LinkGeneric 01/2022
1	Cartilage Oligomeric Matrix ProteinIBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	1,4-alpha-Glucan Branching Enzyme (Glycogen Branching Enzyme)IBA 01/2022
1	LaminsIBA 01/2022
1	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 01/2022
1	Amino Acids FDA Link 01/2021
1	tenascin XIBA 10/2020
1	DysferlinIBA 01/2020
1	Cysteine Proteases (Cysteine Protease)IBA 01/2020
1	CalciumIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	AnoctaminsIBA 01/2020
1	Oxidoreductases (Dehydrogenase)IBA 01/2019
1	Phosphoglycerate Kinase (Kinase, Phosphoglycerate)IBA 01/2019
1	CollagenIBA 08/2018
1	Glycogen Debranching Enzyme System (Glycogen Debranching Enzyme)IBA 01/2018
1	CalsequestrinIBA 01/2018
1	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 01/2017

Therapy/Procedure

1	Spinal Injections 01/2024
1	Therapeutics 01/2023
1	Nutritional Support (Artificial Feeding) 01/2023
1	Precision Medicine 01/2021
1	Transplantation 12/2019